Agonists of the GLP-1 receptor have been shown to increase levels of markers of bone formation (osteocalcin and procollagen type 1 N-terminal propeptide [P1NP]) and protect against loss of bone mineral content in obese women after weight loss while having no effect on plasma CTX-1 concentrations [59, 60]
Afterward, they are stored in the gallbladder, released into the intestinal lumen after a meal, and further metabolized by the gut microbiota into secondary bile acids
This titration minimises gastrointestinal side effects and allows the body to adapt
Ive lost more than 80 pounds in about 13 months, improved my eating habits, stayed more active, and gained confidence along the way
Wise LA, Willis SK, Mikkelsen EM, et al